Replies to post #341065 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

Lol.

Nasrat never wanted to switch.

These products were supposed to be launched in addition to the CNS products.

He was afraid of potential lawsuits.....even though there will never be one for Elite.

Nasrat even stated in the CC he was quote "disappointed" that we couldn't launch these products. (He CHOSE not to launch them)

As you said switching to CNS was a good decision

[Je3232]

What amazes me that the stock is at six cents and Nasrat says nothing. No new announcements on products / no guidance / just keeps diluting the shares. He needs to step down soon if the stock doesn’t pop. This is a public traded company and he has a responsibility to shareholders , not just Nasrat

[WeeZuhl]

I see a lot of complaining why pain ANDAs never got materialized, thanks for thoughtful answer. As you said switching to CNS was a good decision and with the same prorated market share we will double the revenue compare to pain drugs.

I read that post very carefully, and I did not see any answers about why the opioids were never commercialized. Still waiting for that answer, meshcan. Likewise, adding the CNS stimulants instead of switching to them is the most obvious business decision, especially for a company with little income, no access to capital, minimal legal risk, and "going concern" caveats from their auditor.

These are simple, straightforward questions that anyone is welcome to answer. Yes, dear investor, we know you are glad that Nasrat wasted millions of dollars and tens of millions of ELTP shares developing these drugs and then sold them off to his buddies for pennies on the dollar. We know you are happy to have $30M revenue instead of $100M revenue, but why? Make it make sense for us, from a rational business perspective. We're waiting.